Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $3.24B | $6.85B | -52.75% |
Cost of Revenue | $1.46B | $4.69B | -68.80% |
Operating Income | $-3.94B | $-4.24B | +6.94% |
Net Income | $-3.56B | $-4.71B | +24.46% |
EPS (Basic) | $-9.28 | $-12.33 | +24.74% |
EPS (Diluted) | $-9.28 | $-12.33 | +24.74% |
R&D Expense | $4.54B | $4.84B | -6.23% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $14.14B | $18.43B | -23.25% |
Current Assets | $8.1B | $10.32B | -21.56% |
Total Liabilities | $3.24B | $4.57B | -29.11% |
Current Liabilities | $2.21B | $3.02B | -26.83% |
Stockholders' Equity | $10.9B | $13.85B | -21.32% |
Cash & Equivalents | $1.93B | $2.91B | -33.71% |
Long-Term Debt | $0 | — | — |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-3B | $-3.12B | +3.66% |
Investing Cash Flow | $1.95B | $4.21B | -53.66% |
Financing Cash Flow | $56M | $-1.38B | +104.07% |
Share Buybacks | $0 | $1.15B | -100.00% |
D&A | $185M | $617M | -70.02% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -121.9% | -61.9% | -60.01% |
Net Margin | -110.0% | — | — |
ROE | -32.7% | — | — |
ROA | -25.2% | — | — |
Current Ratio | $3.671 | — | — |
Debt to Equity | $0.297 | — | — |
Other companies in Biotechnology